Sign in
8-K

Current Report

Protagenic Therapeutics, Inc.\new Filed Acc 0001170918-07-000738

Executive or director change · Code of ethics change

  • Item 5.02 Departure or appointment of directors or officers
  • Item 5.05 Amendment to or waiver of the code of ethics

From the SEC's structured data for this filing

Loading fm8k-082007.txt…